[Letter to Frank Miedema from Jon Cohen]

patients from the start of the epidemic, was particularly
impressed with these studies. The story looks ''very
convincing,'' he said. But until larger studies confirm these
initial findings, Miedema said that he's reluctant to advise
people with syncytia-inducing HIV not to take AZT--although he
suggested that they should combine it with another antiretroviral drug.